These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17188088)

  • 1. Human immunodeficiency virus and hepatitis testing and prevalence among surgical patients in an urban university hospital.
    Weiss ES; Cornwell EE; Wang T; Syin D; Millman EA; Pronovost PJ; Chang D; Makary MA
    Am J Surg; 2007 Jan; 193(1):55-60. PubMed ID: 17188088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of blood-borne pathogens in an urban, university-based general surgical practice.
    Weiss ES; Makary MA; Wang T; Syin D; Pronovost PJ; Chang D; Cornwell EE
    Ann Surg; 2005 May; 241(5):803-7; discussion 807-9. PubMed ID: 15849516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
    Edeh J; Spalding P
    J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis B virus seroprevalence in an urban trauma population.
    Sloan EP; McGill BA; Zalenski R; Tsui P; Chen EH; Duda J; Morris M; Sherer R; Barrett J
    J Trauma; 1995 May; 38(5):736-41. PubMed ID: 7760401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the factors associated with blood-borne virus testing of substance misusers presenting to hospital.
    Tennant E; Vollmer-Conna U; Demirkol A; Post JJ
    Intern Med J; 2017 Aug; 47(8):907-914. PubMed ID: 28560729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prisons in dissemination of HIV and hepatitis.
    Laurence J
    AIDS Read; 2005 Feb; 15(2):54-5. PubMed ID: 15712392
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
    Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
    Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
    BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States.
    Kim JH; Psevdos G; Suh J; Sharp VL
    World J Gastroenterol; 2008 Nov; 14(43):6689-93. PubMed ID: 19034972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health disparities among African-American and Hispanic drug injectors--HIV, AIDS, hepatitis B virus and hepatitis C virus: a review.
    Estrada AL
    AIDS; 2005 Oct; 19 Suppl 3():S47-52. PubMed ID: 16251828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Hepatitis B Virus, Hepatitis C Virus, and Syphilis Coinfection in People With HIV/AIDS Contracted Through Different Sources: Retrospective Study.
    Yang R; Yuan R; Gui X; Ke H; Zhuang K; Hu H; Li L; Feng L; Yu X; Yan Y; Luo M
    JMIR Public Health Surveill; 2024 Feb; 10():e46750. PubMed ID: 38412004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood borne viral infections among Danish health care workers--frequent blood exposure but low prevalence of infection.
    Fisker N; Mygind LH; Krarup HB; Licht D; Georgsen J; Christensen PB
    Eur J Epidemiol; 2004; 19(1):61-7. PubMed ID: 15012024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
    O'Connell S; Lillis D; Cotter A; O'Dea S; Tuite H; Fleming C; Crowley B; Fitzgerald I; Dalby L; Barry H; Shields D; Norris S; Plunkett PK; Bergin C
    PLoS One; 2016; 11(3):e0150546. PubMed ID: 26967517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and HCV screening among trauma patients.
    Simoncini GM; Oyola-Jimenez J; Singleton D; Volgraf J; Ramsey FV; Goldberg A
    Int J STD AIDS; 2019 Jun; 30(7):663-670. PubMed ID: 30961465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale against preoperative screening for HIV in Polish hospitals: a prevalence study of anti-HIV in contrast to anti-hepatitis C virus and hepatitis B surface antigen.
    Gańczak M; Szych Z
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1227-9. PubMed ID: 19863442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.